Marcio Souza
Chief Executive Officer bei PRAXIS PRECISION MEDICINES, INC.
Vermögen: 926 040 $ am 31.03.2024
Profil
Marcio Souza is the President, Chief Executive Officer & Director at Praxis Precision Medicines, Inc. He previously worked as the Executive Director-Marketing at NPS Pharmaceuticals, Inc. and as the Chief Operating Officer at PTC Therapeutics, Inc. He also served as an Independent Director at Clearpoint Neuro, Inc. and Spyre Therapeutics, Inc. Mr. Souza holds an MBA from Fundação Dom Cabral and an undergraduate degree from the University of Sao Paulo.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
12.02.2024 | 15 176 ( 0,11% ) | 926 040 $ | 31.03.2024 |
Aktive Positionen von Marcio Souza
Unternehmen | Position | Beginn |
---|---|---|
PRAXIS PRECISION MEDICINES, INC. | Chief Executive Officer | 01.04.2020 |
Ehemalige bekannte Positionen von Marcio Souza
Unternehmen | Position | Ende |
---|---|---|
SPYRE THERAPEUTICS, INC. | Director/Board Member | 22.06.2023 |
CLEARPOINT NEURO, INC. | Director/Board Member | 27.04.2020 |
PTC THERAPEUTICS, INC. | Chief Operating Officer | 01.04.2020 |
NPS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.07.2014 |
Ausbildung von Marcio Souza
Fundação Dom Cabral | Masters Business Admin |
University of Sao Paulo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
SPYRE THERAPEUTICS, INC. | Health Technology |
CLEARPOINT NEURO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Praxis Precision Medicines, Inc. |